| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA" | 25510870 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA" | 25510870 |
| C030370 | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | "2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of PRUNE2 mRNA" | 20206263 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in decreased expression of PRUNE2 mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PRUNE2 mRNA | 29067470 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of PRUNE2 gene | 27153756 |
| D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of PRUNE2 mRNA | 21298039 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PRUNE2 mRNA | 20106945 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of PRUNE2 mRNA | 17404688 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased expression of PRUNE2 mRNA | 27685785 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PRUNE2 mRNA | 27685785 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRUNE2 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PRUNE2 mRNA | 25181051 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of PRUNE2 mRNA | 15336504 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of PRUNE2 mRNA | 25993096 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of PRUNE2 mRNA | 25979313 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of PRUNE2 mRNA | 20106945 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of PRUNE2 mRNA | 25047013 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRUNE2 mRNA | 28628672 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of PRUNE2 mRNA | 25380136 |
| C118739 | entinostat | entinostat results in decreased expression of PRUNE2 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of PRUNE2 mRNA | 28973697 |
| D006854 | Hydrocortisone | Hydrocortisone results in decreased expression of PRUNE2 mRNA | 21267416 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRUNE2 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PRUNE2 mRNA | 28628672 |
| D007854 | Lead | Lead affects the expression of PRUNE2 mRNA | 28903495 |
| D008558 | Melphalan | Melphalan results in decreased expression of PRUNE2 mRNA | 22363485 |
| C042720 | mercuric bromide | mercuric bromide results in decreased expression of PRUNE2 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| D008694 | Methamphetamine | Methamphetamine results in increased expression of PRUNE2 mRNA | 26307267 |
| D008727 | Methotrexate | Methotrexate results in increased expression of PRUNE2 mRNA | 24449571 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of PRUNE2 mRNA | 28001369 |
| C030589 | methylmercury cysteine | methylmercury cysteine results in decreased expression of PRUNE2 mRNA | 19465457 |
| C523799 | MRK 003 | PRUNE2 results in increased susceptibility to MRK 003 | 19903844 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in decreased expression of PRUNE2 mRNA | 25380136 |
| D009532 | Nickel | Nickel results in decreased expression of PRUNE2 mRNA | 25583101 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of PRUNE2 mRNA | 22714537 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of PRUNE2 mRNA | 25729387 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of PRUNE2 mRNA | 25729387 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of PRUNE2 mRNA | 24236059 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in decreased expression of PRUNE2 mRNA | 26272509 |
| D052638 | Particulate Matter | Particulate Matter results in decreased methylation of PRUNE2 gene | 28495853 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRUNE2 mRNA" | 25510870 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of PRUNE2 mRNA | 26272509 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of PRUNE2 mRNA | 22714537 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of PRUNE2 mRNA | 17404688 |
| C009277 | sodium arsenate | sodium arsenate results in decreased expression of PRUNE2 mRNA | 21795629 |
| C004648 | testosterone enanthate | testosterone enanthate affects the expression of PRUNE2 mRNA | 17440010 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PRUNE2 mRNA | 20106945 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PRUNE2 mRNA | 26232522 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of PRUNE2 mRNA | 23409001 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of PRUNE2 mRNA | 20133372 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of PRUNE2 mRNA | 25729387 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PRUNE2 mRNA | 21934132 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PRUNE2 mRNA | 16288218 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of PRUNE2 mRNA | 24935251|2627250 |
| C012589 | trichostatin A | trichostatin A results in increased expression of PRUNE2 mRNA | 24935251 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of PRUNE2 mRNA | 19042947 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRUNE2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of PRUNE2 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PRUNE2 mRNA | 28001369 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of PRUNE2 gene | 28495853 |
| C111237 | vorinostat | vorinostat results in decreased expression of PRUNE2 mRNA | 27188386 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of PRUNE2 mRNA | 24714768 |